PMC Articles for PubChem Compound (Select 159516) - PMC

Result Filters

Links from PubChem Compound

Items: 11

Select item 94639201.

Chemosensitizing Effect and Efficacy of Wilforlide A in Combination With Docetaxel in Drug-resistant Prostate Cancer

ZHIJUN WANG, STEVEN YEUNG, SHANCHAO YANG, YING HUANG, MOSES SING SUM CHOW

In Vivo. 2022 Sep-Oct; 36(5): 2020–2031. Published online 2022 Sep 3. doi: 10.21873/invivo.12928

PMCID:: PMC9463920

Abstract Article PDF–4.7M

Select item 93639742.

Lupeol and pristimerin do not inhibit activation of the human sperm CatSper Ca(2+)-channel

Anders Rehfeld, Christian Marcus Pedersen

Version 2. F1000Res. 2022; 11: 222. Published online 2022 Aug 2. doi: 10.12688/f1000research.109279.2

PMCID:: PMC9363974

Abstract Article PDF–1.4M

Select item 93599263.

Potential medicinal plants involved in inhibiting 3CL^pro activity: A practical alternate approach to combating COVID-19

Fan Yang, Xiao-lan Jiang, Akash Tariq, Sehrish Sadia, Zeeshan Ahmed, Jordi Sardans, Muhammad Aleem, Riaz Ullah, Rainer W. Bussmann

J Integr Med. 2022 Nov; 20(6): 488–496. Published online 2022 Aug 9. doi: 10.1016/j.joim.2022.08.001

PMCID:: PMC9359926

Abstract Article PDF–1.1M

Select item 90389484.

Pristimerin exerts antitumor activity against MDA-MB-231 triple-negative breast cancer cells by reversing of epithelial-mesenchymal transition via downregulation of integrin β3

Shiyue Liu, Youhong Dong, Ying Wang, Pengchao Hu, Jing Wang, Robert YL. Wang

Biomed J. 2021 Dec; 44(6 Suppl 1): S84–S92. Published online 2020 Jul 25. doi: 10.1016/j.bj.2020.07.004

PMCID:: PMC9038948

Abstract Article PDF–2.3M

Select item 84917405.

Pristimerin inhibits neuronal inflammation and protects cognitive function in mice with sepsis-induced brain injuries by regulating PI3K/Akt signalling

Weimin Xue, Yaqiang Li, Mei Zhang

Pharm Biol. 2021; 59(1): 1349–1356. Published online 2021 Sep 30. doi: 10.1080/13880209.2021.1981399

Retraction in:: Pharm Biol. 2024 Dec; 62(1): 269.

PMCID:: PMC8491740

Abstract Article

Select item 81494136.

Pristimerin protects against inflammation and metabolic disorder in mice through inhibition of NLRP3 inflammasome activation

Qun Zhao, Yun Bi, Jian Guo, Ying-xiang Liu, Jing Zhong, Long-rui Pan, Yan Tan, Xian-jun Yu

Acta Pharmacol Sin. 2021 Jun; 42(6): 975–986. Published online 2020 Sep 28. doi: 10.1038/s41401-020-00527-x

PMCID:: PMC8149413

Abstract Article PDF–3.2M

Select item 78004677.

Pristimerin Protects Against OVX-Mediated Bone Loss by Attenuating Osteoclast Formation and Activity via Inhibition of RANKL-Mediated Activation of NF-κB and ERK Signaling Pathways

Xuedong Li, Xixi Lin, Zuoxing Wu, Yuangang Su, Jiamin Liang, Runfeng Chen, Xue Yang, Lei Hou, Jinmin Zhao, Qian Liu, Feng Xu

Drug Des Devel Ther. 2021; 15: 61–74. Published online 2021 Jan 7. doi: 10.2147/DDDT.S283694

PMCID:: PMC7800467

Abstract Article PDF–7.2M

Select item 76464438.

Pristimerin Suppresses Trophoblast Cell Epithelial–Mesenchymal Transition via miR-542-5p/EGFR Axis

Chang Shu, Xiaowei Yu, Shihuan Cheng, Jili Jing, Cong Hu, Bo Pang

Drug Des Devel Ther. 2020; 14: 4659–4670. Published online 2020 Nov 2. doi: 10.2147/DDDT.S274595

PMCID:: PMC7646443

Abstract Article PDF–6.3M

Select item 75537709.

Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo

Peng Sun, Qichang Yang, Yanben Wang, Jiaxuan Peng, Kangxian Zhao, Yewei Jia, Tan Zhang, Xuanyuan Lu, Weiqi Han, Yu Qian

Drug Des Devel Ther. 2020; 14: 4189–4203. Published online 2020 Oct 9. doi: 10.2147/DDDT.S275128

PMCID:: PMC7553770

Abstract Article PDF–13M

Select item 630407910.

Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways

Dina S El-Agamy, Khaled M El-Harbi, Saad Khoshhal, Nishat Ahmed, Mohamed A Elkablawy, Ahmed A Shaaban, Hany M Abo-Haded

Cancer Manag Res. 2019; 11: 47–61. Published online 2018 Dec 19. doi: 10.2147/CMAR.S186696

PMCID:: PMC6304079

Abstract Article PDF–3.8M

Select item 588382811.

Pristimerin as a Novel Hepatoprotective Agent Against Experimental Autoimmune Hepatitis

Dina S. El-Agamy, Ahmed A. Shaaban, Hamdi H. Almaramhy, Sarah Elkablawy, Mohamed A. Elkablawy

Front Pharmacol. 2018; 9: 292. Published online 2018 Mar 28. doi: 10.3389/fphar.2018.00292

PMCID:: PMC5883828

Abstract Article PDF–3.9M

Supplemental Content

Filter your results:

All (11)
NIH grants (0)
Embargoed (0)

Manage Filters

Find related data

Recent activity

Clear Turn Off Turn On

PMC Articles for PubChem Compound (Select 159516) (11)
PMC

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

You are here: NCBI > Literature > PubMed Central (PMC)

Support Center

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to: